cerrar
Tagged with Regulation

Interview: Pascal Strupler – Director General, Federal…
Pascal Strupler of the Federal Office of Public Health discusses the intricacies of the Swiss healthcare system, highlighting the importance of the…

Interview: Dr. Catherine Chammartin – Director General,…
Dr. Catherine Chammartin of the Swiss Federal Institute of Intellectual Property (IPI) describes the strong elements of an IP system and its…

Interview: Raúl Riquelme Cacho – President of the Health…
Raúl Riquelme Cacho, president of the health commission of the Confederation of Industrial Chambers of the United Mexican States (CONCAMIN), reveals…

Interview: Oscar Parra – General Manager, Lundbeck Mexico
Lundbeck Mexico GM Oscar Parra discusses raising awareness of depression in Mexico, Lundbeck’s innovative treatments for depression and…

Interview: Dr. Leisha Daly – Country Director, Janssen;…
Dr. Leisha Daly, Janssen Ireland country director and president of the Irish Pharmaceutical Healthcare Association (IPHA) discusses her presidency and…

Interview: Roberto Martinez – General Director, OECD Mexico…
In light of the recently released OECD Reviews of Health Systems: Mexico 2016, Roberto Martinez, general director of the OECD Mexico Center for Latin…

Interview: Gabriel O’Shea – National Commissioner, Seguro…
Gabriel O’Shea, National Commissioner of Seguro Popular, on how the institute generates more efficient and transparent resource allocation across…

Interview: Mikel Arriola – General Director, IMSS, Mexico…
In part two of a two-part interview (read part one here), Mikel Arriola of the IMSS discusses the strategic roadmap IMSS will follow under his tenure…

Interview: Mikel Arriola – General Director, IMSS, Mexico…
In part one of a two-part interview (read part two here), Mikel Arriola, the recently appointed general director of IMSS (Mexican Social Security…

Interview: Radek Korbel – Head of Affiliate, Sanofi-Genzyme…
The Head of Sanofi-Genzyme’s Czech & Slovak affiliate points out that his affiliate generates a third of the regional turnover for the group as…

Interview: Julio Sánchez y Tépoz – Federal Commissioner,…
Building on the continuous improvements of the Federal Commission for the Protection Against Sanitary Risk (Cofepris) over the last few years, its…

Bottlenecks in French Pharma
The following chart illustrates the various bottlenecks restraining the development of France's pharmaceutical industry, including lack of…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here